Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_04980 |
| Species: | Mus musculus |
| Position : | chr5:87705429-87705829 |
| Year: | 2011 |
| Title: | Progesterone receptor directly inhibits ζ±-casein gene transcription in mammary epithelial cells through promoting promoter and enhancer repressive chromatin modifications. |
| Genome Build: | mm10 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 21527503 |
| Tissue: | mammary gland |
| Tissue Ontology ID: | UBERON:0001911 |
| Cell Source: | HC11 |
| CVCL ID: | CVCL_0288 |
| Cell Type: | epithelial cell of mammary gland |
| Experiment Type: | Enhancer occupancy assay; Chromatin modification assay; Functional hormone-response assay |
| Low Throughput Method: | ChIP-qPCR; prolactin/hydrocortisone/R5020 hormone perturbation; histone-modification ChIP; RT-qPCR; Western blot |
| Target gene : | Csn2 |
| TF name : | Cebpb |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| Cebpb | C-MYB transcription factor network | pid | 87 |
| Cebpb | EGFR1 | netpath | 475 |
| Cebpb | FOXA1 transcription factor network | pid | 45 |
| Cebpb | FOXA2 and FOXA3 transcription factor networks | pid | 45 |
| Cebpb | IFN-gamma pathway | pid | 43 |
| Cebpb | IL3-mediated signaling events | pid | 27 |
| Cebpb | IL4-mediated signaling events | pid | 66 |
| Cebpb | IL4 | netpath | 75 |
| Cebpb | IL6-mediated signaling events | pid | 48 |
| Cebpb | IL6 | netpath | 85 |
| Cebpb | RANKL | netpath | 84 |
| Cebpb | Regulation of nuclear SMAD2/3 signaling | pid | 82 |
| Cebpb | Regulation of retinoblastoma protein | pid | 67 |
| Cebpb | Senescence-Associated Secretory Phenotype (SASP) | reactome | 108 |
| Cebpb | Signaling mediated by p38-alpha and p38-beta | pid | 35 |
| Cebpb | TCR | netpath | 261 |
| Cebpb | Transcriptional regulation of white adipocyte differentiation | reactome | 79 |
| Cebpb | Validated nuclear estrogen receptor alpha network | pid | 65 |
| Cebpb | Hs_Senescence_and_Autophagy_in_Cancer_WP615_81193 | wikipathways | 62 |
| Cebpb | Hs_Oncostatin_M_Signaling_Pathway_WP2374_73668 | wikipathways | 44 |
| Cebpb | Hs_Transcriptional_activation_by_NRF2_WP3_79527 | wikipathways | 6 |
| Cebpb | Hs_Lung_fibrosis_WP3624_91475 | wikipathways | 23 |
| Cebpb | Hs_IL17_signaling_pathway_WP2112_89838 | wikipathways | 20 |